Cargando…
Shikonin potentiates paclitaxel antitumor efficacy in esophageal cancer cells via the apoptotic pathway
Shikonin is a natural naphthoquinone pigment that can suppress the growth of a number of cancer cell types. Paclitaxel is an antineoplastic chemotherapy drug, which is used for the treatment of various types of solid tumor cancer. However, acquired paclitaxel resistance results in the failure of the...
Autores principales: | Du, Wenzhen, Hao, Xiaohong, Yuan, Zhili, Wang, Ying, Zhang, Xueguang, Liu, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6704285/ https://www.ncbi.nlm.nih.gov/pubmed/31452796 http://dx.doi.org/10.3892/ol.2019.10662 |
Ejemplares similares
-
Efficacy of Shikonin against Esophageal Cancer Cells and its possible mechanisms in vitro and in vivo
por: Tang, Jian-Cai, et al.
Publicado: (2018) -
Induction of apoptosis by Shikonin through ROS-mediated intrinsic and extrinsic apoptotic pathways in primary effusion lymphoma
por: Alam, Md Masud, et al.
Publicado: (2021) -
Shikonin Exerts Cytotoxic Effects in Human Colon Cancers by Inducing Apoptotic Cell Death via the Endoplasmic Reticulum and Mitochondria-Mediated Pathways
por: Han, Xia, et al.
Publicado: (2019) -
Integration of Transcriptomics and Metabolomics Reveals the Antitumor Mechanism Underlying Shikonin in Colon Cancer
por: Chen, Yang, et al.
Publicado: (2020) -
Shikonin suppresses NEAT1 and Akt signaling in treating paclitaxel-resistant non-small cell of lung cancer
por: Zang, Farong, et al.
Publicado: (2020)